Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Martin Dow is a multinational pharmaceutical and healthcare group headquartered in Pakistan with a significant presence in Europe and the Middle East. The company specializes in the development, manufacturing, and marketing of branded generic pharmaceuticals across a wide range of therapeutic areas, including CNS, cardiology, gastroenterology, and anti-infectives. Martin Dow grew rapidly through strategic acquisitions of manufacturing facilities and product portfolios from global leaders such as Roche and Merck KGaA. The company operates high-standard manufacturing sites in Karachi, Pakistan, and Meymac, France, positioning itself as a key regional player and a partner for multinational corporations in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Martin Dow.